EPI

La Banque Postale and JCB join forces to elevate payments experience for travellers in France

Retrieved on: 
Tuesday, March 26, 2024

The partnership between La Banque Postale and JCB offers a variety of payment options to business owners and benefits to JCB cardmembers.

Key Points: 
  • The partnership between La Banque Postale and JCB offers a variety of payment options to business owners and benefits to JCB cardmembers.
  • La Banque Postale has a strong physical presence across France, with 17,000 points of contact including 7,000 post offices, and an extensive network of 6,000 ATMs.
  • As a member of the European Payments Initiative (EPI) and deeply committed to international payments, La Banque Postale is a major player on the payments front.
  • France is a key market for JCB, and the collaboration with La Banque Postale is an important pillar in JCB's strategy to increase its acceptance across Europe.

Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024

Retrieved on: 
Monday, May 6, 2024

Initial data from at least 20 patients from the Phase 1 clinical trial of LYL797 are expected this quarter.

Key Points: 
  • Initial data from at least 20 patients from the Phase 1 clinical trial of LYL797 are expected this quarter.
  • Initial clinical and translational data from the Phase 1 trial of LYL845 are expected in the second half of 2024.
  • Research and development (R&D) expenses were $43.2 million for the first quarter ended March 31, 2024, compared to $44.6 million for the same period in 2023.
  • The decrease in first quarter 2024 non-GAAP R&D expenses was primarily driven by a decrease in personnel-related expenses.

BTP Business is Booming for Brazilian Firms, SAP Providers

Retrieved on: 
Wednesday, May 8, 2024

The 2024 ISG Provider Lens™ SAP Ecosystem report for Brazil finds that the development and integration of SAP BTP has led to a significant increase in the number of platform developers and BTP-certified professionals.

Key Points: 
  • The 2024 ISG Provider Lens™ SAP Ecosystem report for Brazil finds that the development and integration of SAP BTP has led to a significant increase in the number of platform developers and BTP-certified professionals.
  • The aim is to keep the digital core clean, using SAP BTP as the hub and S/4HANA on-premises or in the private or public cloud, the ISG report says.
  • The 2024 ISG Provider Lens™ SAP Ecosystem report for Brazil evaluates the capabilities of 47 providers across five quadrants: SAP S/4HANA System Transformation for Large Accounts, SAP S/4HANA System Transformation for Midmarket, SAP Application Managed Services, Managed Cloud Services for SAP ERP and SAP SuccessFactors HXM Partner Services.
  • In the area of customer experience, Infosys is named the global ISG CX Star Performer for 2024 among SAP Ecosystem providers.

Vishay selects AIXTRON SiC multiwafer batch technology

Retrieved on: 
Friday, May 3, 2024

Vishay is one of the world's largest manufacturers of discrete semiconductors and passive electronic components.

Key Points: 
  • Vishay is one of the world's largest manufacturers of discrete semiconductors and passive electronic components.
  • This, in combination with an excellent uniformity performance on 200mm wafers, has made us choose AIXTRON technology.
  • The AIXTRON team has developed a unique solution for the tightest control of doping levels and uniformity on 200 mm SiC wafers.
  • First introduced in September 2022, AIXTRON’s G10-SiC has quickly become the tool of record for both 150 mm and 200 mm SiC epitaxy.

Pazanga Health Communications Social Media Marketing Work Honored in 2024 American Business Awards®

Retrieved on: 
Wednesday, May 1, 2024

The collective work submitted included a showcase of the strategy and results for the brand’s organic social media, paid social media marketing campaigns for healthcare practitioners and prospective patients, community engagement, influencer social media marketing, and social-focused content and video development.

Key Points: 
  • The collective work submitted included a showcase of the strategy and results for the brand’s organic social media, paid social media marketing campaigns for healthcare practitioners and prospective patients, community engagement, influencer social media marketing, and social-focused content and video development.
  • “Social media has continued to evolve in the healthcare industry, and for the Pazanga team, it’s become a critical element to many of our clients’ strategies,” said CEO Laura Nobles .
  • “This award is an incredible recognition of the forward-thinking creativity, innovation, and strategy behind the Alpha-Stim social media marketing work, and the power of social media and community engagement in today’s world.”
    The American Business Awards are the U.S.A.’s premier business awards program.
  • “We started 2023 with the goals to increase brand awareness, overall organic social performance, and to drive the sales funnel downward.

WorkForce Software Announces Partner Excellence Award Winners: Accenture, EPI-USE, Intelligenza IT, and SAP SuccessFactors, as Growing Demand for Workforce Management Technology and Global Expansion Continue in 2024

Retrieved on: 
Wednesday, April 24, 2024

WorkForce Software , the #1 rated workforce management solution for large employers, announces the winners of its Partner Excellence Awards.

Key Points: 
  • WorkForce Software , the #1 rated workforce management solution for large employers, announces the winners of its Partner Excellence Awards.
  • These exceptional partners were celebrated at WorkForce Software’s VISION 2024 Ignite Conference in Florida's Gold Coast.
  • Regional Software Implementation Partner of the Year: Intelligenza IT is recognized for their dedication to excellence in delivering exceptional WorkForce Software implementations across Latin America.
  • To learn more about WorkForce Software, its market-leading WorkForce Suite solution, and its wide-reaching partner ecosystem , read more here .

EPI Health, LLC Issues Voluntary Recall

Retrieved on: 
Tuesday, April 23, 2024

The EPI Health/Novan Trustee is initiating a voluntary recall of various within-expiry human drug products (Attachment 1) as a result of the closures and discontinuation of the post-marketing quality, regulatory and pharmacovigilance activities for these marketed products.

Key Points: 
  • The EPI Health/Novan Trustee is initiating a voluntary recall of various within-expiry human drug products (Attachment 1) as a result of the closures and discontinuation of the post-marketing quality, regulatory and pharmacovigilance activities for these marketed products.
  • EPI Health has not received any reports of adverse events related to this recall.
  • EPI Health, LLC is notifying its distributors and direct consignees by direct mailing and is requesting they further notify their customers/consumers/retailers.
  • Consumers with questions regarding this recall can contact EPI Health at Phone: 888-671-8858 during normal business hours (8am – 5pm CDT) Monday – Friday or thru email at [email protected] .

Piero Cipollone: Innovation, integration and independence: taking the Single Euro Payments Area to the next level

Retrieved on: 
Thursday, April 25, 2024

This paper investigates the sensitivity of the demand for safe government debt to currency unhedged and hedged excess returns in a sample of US mutual funds.

Key Points: 
  • This paper investigates the sensitivity of the demand for safe government debt to currency unhedged and hedged excess returns in a sample of US mutual funds.
  • We find evidence of active rebalancing towards government bonds that offer relatively higher returns on an unhedged basis, in particular euro denominated securities.

EQS-News: Epigenomics AG publishes financial results for fiscal year 2023

Retrieved on: 
Wednesday, April 10, 2024

Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial results (according to HGB) for fiscal year 2023.

Key Points: 
  • Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial results (according to HGB) for fiscal year 2023.
  • In July 2023, Epigenomics AG entered into an agreement with New Day Diagnostics LLC for the sale of substantially all of its assets, which was approved by the Extraordinary General Meeting in September 2023 and closed in October 2023.
  • Based on the measures taken, Epigenomics AG expects that the available financial resources will be sufficient until 2026.
  • The annual financial statements for the 2023 fiscal year can be found on the Epigenomics website at: https://www.epigenomics.com/news-investors/financial-reports/ .

TurnOnGreen and Endliss Power Team up to Expand Electric Vehicle Charging Infrastructure Across North America

Retrieved on: 
Thursday, March 14, 2024

The collaboration marks a milestone for the Company as it seeks to expand its networked electric vehicle (“EV”) charging infrastructure across North America, leveraging EPI’s expertise in administering and executing power purchase agreements with commercial clients.

Key Points: 
  • The collaboration marks a milestone for the Company as it seeks to expand its networked electric vehicle (“EV”) charging infrastructure across North America, leveraging EPI’s expertise in administering and executing power purchase agreements with commercial clients.
  • View the full release here: https://www.businesswire.com/news/home/20240314154068/en/
    TurnOnGreen EV Charger with Solar Panel System All copyrights reserved @2024 TurnOnGreen, Inc.
  • Under this partnership, TurnOnGreen and EPI will deliver comprehensive sustainability solutions for installing, operating, and maintaining utility-scale solar power, energy storage systems, and EV charging stations.
  • “We are pleased to partner with Endliss Power to expand our sustainability product portfolio and provide prospective clients with a diverse range of purchasing options for EV charging infrastructure,” said Marcus Charuvastra, President of TurnOnGreen.